10-QFiling Date: Aug 7, 2026
Merck (MRK) 10-Q: Quarterly Report · ended 2026-06-30 · Rev $16.6B, NI -$1.3B (Aug 7, 2026)
mrk-20260630
View SEC Filing
ACC: 0000310158-26-000212
Key Financial MetricsFY2026 · 2026-06-30
Revenue$16.61B
Net Income-$1.33B
Total Assets$129.80B
Stockholders' Equity$41.93B
Operating Cash Flow$9.29B